501 related articles for article (PubMed ID: 23103194)
21. Seroprevalence of rubella among Jordanian women of childbearing age.
Jarour N; Hayajneh WA; Balbeesi A; Otoom H; Al-Shurman A; Kharabsheh S
Vaccine; 2007 May; 25(18):3615-8. PubMed ID: 17280747
[TBL] [Abstract][Full Text] [Related]
22. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan.
Chiu HH; Lee CY; Chih TW; Lee PI; Chang LY; Lin YJ; Hsu CM; Huang LM
J Med Virol; 1997 Jan; 51(1):32-5. PubMed ID: 8986946
[TBL] [Abstract][Full Text] [Related]
23. Measles in Papua New Guinea: an age-specific serological survey.
Senn N; Riddell M; Omena M; Siba P; Reeder JC; Clements CJ; Morgan C
Vaccine; 2010 Feb; 28(7):1819-23. PubMed ID: 20018264
[TBL] [Abstract][Full Text] [Related]
24. Reducing the global burden of congenital rubella syndrome: report of the World Health Organization Steering Committee On Research Related To Measles and Rubella Vaccines and Vaccination, June 2004.
Best JM; Castillo-Solorzano C; Spika JS; Icenogle J; Glasser JW; Gay NJ; Andrus J; Arvin AM
J Infect Dis; 2005 Dec; 192(11):1890-7. PubMed ID: 16267759
[TBL] [Abstract][Full Text] [Related]
25. Fetal risk associated with rubella vaccination during pregnancy.
Badilla X; Morice A; Avila-Aguero ML; Saenz E; Cerda I; Reef S; Castillo-Solórzano C
Pediatr Infect Dis J; 2007 Sep; 26(9):830-5. PubMed ID: 17721380
[TBL] [Abstract][Full Text] [Related]
26. Simulations of rubella vaccination strategies in China.
Gao L; Hethcote H
Math Biosci; 2006 Aug; 202(2):371-85. PubMed ID: 16603207
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of antibodies to measles and rubella in Sana'a, Yemen.
Sallam TA; Al-Jaufy AY; Al-Shaibany KS; Ghauth AB; Best JM
Vaccine; 2006 Sep; 24(37-39):6304-8. PubMed ID: 16815602
[TBL] [Abstract][Full Text] [Related]
28. Age-specific prevalence of IgG against measles/rubella and the impact of routine and supplementary immunization activities: A multistage random cluster sampling study with mathematical modelling.
Hachiya M; Vynnycky E; Mori Y; Do HT; Huynh MK; Trinh LH; Nguyen DD; Tran NAT; Hoang TT; Hoang HHT; Vo NDT; Le TH; Ichimura Y; Miyano S; Okawa S; Thandar MM; Yokobori Y; Inoue Y; Mizoue T; Takeda M; Komada K
Int J Infect Dis; 2024 Jul; 144():107053. PubMed ID: 38641317
[TBL] [Abstract][Full Text] [Related]
29. Follow-up study of unknowingly pregnant women vaccinated against rubella in Brazil, 2001-2002.
Soares RC; Siqueira MM; Toscano CM; Maia Mde L; Flannery B; Sato HK; Will RM; Rodrigues RC; Oliveira IC; Barbosa TC; Sá GR; Rego MF; Curti SP; Lemos XR; Morhdieck R; Stürmer D; Oliveira MJ; Barbosa da Silva Junior J; Castillo-Solórzano C; Camacho LA; Luna E
J Infect Dis; 2011 Sep; 204 Suppl 2():S729-36. PubMed ID: 21954274
[TBL] [Abstract][Full Text] [Related]
30. Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium.
Theeten H; Hutse V; Hens N; Yavuz Y; Hoppenbrouwers K; Beutels P; Vranckx R; Van Damme P
Epidemiol Infect; 2011 Apr; 139(4):494-504. PubMed ID: 20587123
[TBL] [Abstract][Full Text] [Related]
31. Serum levels of rubella-specific antibodies in Swedish women following three decades of vaccination programmes.
Kakoulidou M; Forsgren M; Lewensohn-Fuchs I; Johansen K
Vaccine; 2010 Jan; 28(4):1002-7. PubMed ID: 19925909
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of measles and rubella vaccination one year after the nationwide campaign in Shiraz, Iran.
Pourabbas B; Ziyaeyan M; Alborzi A; Mardaneh J
Int J Infect Dis; 2008 Jan; 12(1):43-6. PubMed ID: 17950020
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of HI antibody titer against rubella virus to determine the effect of mass vaccination in Tehran.
Soleimanjahi H; Bamdad T; Fotouhi F; Roustai MH; Faghihzadeh S
J Clin Virol; 2005 Oct; 34(2):153-4. PubMed ID: 16076562
[TBL] [Abstract][Full Text] [Related]
34. [Seroprevalence of rubella in Kinshasa (Zaire)].
Omanga U; Goussard B; Kapepela K; Bamba M; Salaun JJ; Piollet M
Bull Soc Pathol Exot; 1991; 84(5 Pt 5):994-1001. PubMed ID: 1819439
[TBL] [Abstract][Full Text] [Related]
35. Progress Toward Rubella and Congenital Rubella Syndrome Control - South-East Asia Region, 2000-2016.
Khanal S; Bahl S; Sharifuzzaman M; Dhongde D; Pattamadilok S; Reef S; Morales M; Dabbagh A; Kretsinger K; Patel M
MMWR Morb Mortal Wkly Rep; 2018 Jun; 67(21):602-606. PubMed ID: 29851943
[TBL] [Abstract][Full Text] [Related]
36. Rubella outbreak in the Netherlands, 2004-2005: high burden of congenital infection and spread to Canada.
Hahné S; Macey J; van Binnendijk R; Kohl R; Dolman S; van der Veen Y; Tipples G; Ruijs H; Mazzulli T; Timen A; van Loon A; de Melker H
Pediatr Infect Dis J; 2009 Sep; 28(9):795-800. PubMed ID: 19710586
[TBL] [Abstract][Full Text] [Related]
37. Prevention of congenital rubella syndrome--what makes sense in 2006?
Robinson JL; Lee BE; Preiksaitis JK; Plitt S; Tipples GA
Epidemiol Rev; 2006; 28():81-7. PubMed ID: 16775038
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology of acute rubella infection in Zambia during the pre-vaccination period (2005-2016) as a baseline for monitoring rubella epidemiology in the post-rubella vaccine introduction era.
Mazaba ML; Siziya S; Monze M; Cohen D
BMC Infect Dis; 2020 Feb; 20(1):101. PubMed ID: 32013873
[TBL] [Abstract][Full Text] [Related]
39. The 2001 serological survey in the Czech Republic--rubella.
Mrázová M; Smelhausová M; Sestáková Z; Svandová E; Benes C
Cent Eur J Public Health; 2003 Dec; 11 Suppl():S42-9. PubMed ID: 15080259
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of immunity against rubella in Iranian after mass campaign for measles-rubella vaccination on December 2003.
Hamkar R; Jalilvand S; Mokhtari-Azad T; Jelyani KN; Nategh R
Am J Infect Control; 2006 Nov; 34(9):588-92. PubMed ID: 17097454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
